Research ArticleClinical Studies

CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment

TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, KEISUKE KAZAMA, KEISUKE KOMORI, MASAKATSU NUMATA, AYAKO TAMAGAWA, MOMOKO FUKUDA, HARUHIKO CHO, JUNYA MORITA, SUZUE YOSHIZAWA, KAZUKI OTANI, AYA KATO, MIE TANABE, MASATO NAKAZONO, SHINNOSUKE KAWAHARA, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA and YASUSHI RINO
Anticancer Research February 2024, 44 (2) 815-822; DOI: https://doi.org/10.21873/anticanres.16873

This article has a correction. Please see:

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment
TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, KEISUKE KAZAMA, KEISUKE KOMORI, MASAKATSU NUMATA, AYAKO TAMAGAWA, MOMOKO FUKUDA, HARUHIKO CHO, JUNYA MORITA, SUZUE YOSHIZAWA, KAZUKI OTANI, AYA KATO, MIE TANABE, MASATO NAKAZONO, SHINNOSUKE KAWAHARA, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA, YASUSHI RINO
Anticancer Research Feb 2024, 44 (2) 815-822; DOI: 10.21873/anticanres.16873
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords